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A B S T R A C T
In the developing central nervous system (CNS), extracellular matrix (ECM) molecules have regulating roles such
as in brain development, neural-circuit maturation, and synaptic-function control. However, excluding the
perineuronal net (PNN) area, the distribution, constituent elements, and expression level of granular ECM
molecules (diffuse ECM) present in the mature CNS remain unclear. Diffuse ECM molecules in the CNS share the
components of PNNs and are likely functional. As cortical functions are greatly region-dependent, we hy-
pothesized that ECM molecules would differ in distribution, expression level, and components in a region- and
layer-dependent manner. We examined the layer-specific expression of several chondroitin sulfate proteoglycans
(aggrecan, neurocan, and brevican), tenascin-R, Wisteria floribunda agglutinin (WFA)-positive molecules, hya-
luronic acid, and link protein in the somatosensory and piriform cortices of mature mice. Furthermore, we
investigated expression changes in WFA-positive molecules due to aging. In the somatosensory cortex, PNN
density was particularly high at layer 4 (L4), but not all diffuse ECM molecules were highly expressed at L4
compared to the other layers. There was almost no change in tenascin-R and hyaluronic acid in any somato-
sensory-cortex layer. Neurocan showed high expression in L1 of the somatosensory cortex. In the piriform cortex,
many ECM molecules showed higher expression in L1 than in the other layers. However, hyaluronic acid showed
high expression in deep layers. Here, we clarified that ECM molecules differ in constituent elements and ex-
pression in a region- and layer-dependent manner. Region-specific expression of ECM molecules is possibly
related to functions such as region-specific plasticity and vulnerability.
Introduction
In the mature central nervous system (CNS), extracellular matrix
(ECM) molecules are distributed as granular ECM molecules (diffuse
ECM molecules) or concentrated meshwork structured perineuronal
nets (PNNs) (Celio et al., 1998; Maeda, 2015). Generally, the ECM fills
the extracellular region of all organs and tissues and contains water and
ions (Mouw et al., 2014; Maeda, 2015). Unlike other organs, collagen
fibers do not exist in the cortex of the brain, but instead contain many
chondroitin sulfate proteoglycans (CSPGs). The ECM in the CNS is
formed from hyaluronic acid, tenescin-R, glycoprotein, CSPG, and link
protein (Maeda, 2015). Hyaluronic acid binds to CSPG via link protein.
Tenascin-R combines with CSPGs. However, these relationships have
been investigated only in the PNN area (the area the PNN occupies
around the neuron) and the relationships of ECM molecules existing
outside the PNN area remain unknown. The ECM molecules of the CNS
regulate neuronal migration, axon outgrowth, synapse formation, and
synapse maturation in the developmental phase (Curran and
D’Arcangelo, 1998; Bandtlow and Zimmermann, 2000; Zimmermann
and Dours-Zimmermann, 2008; Frischknecht and Gundelfinger, 2012).
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In the mature CNS, the function and distribution of ECM molecules
existing outside the PNN area have not been clarified.
In the CNS, there is PNN in the structure where ECM molecules are
condensed. The PNN is a reticular structure surrounding the neuronal
soma, axon initial segment, and proximal dendrites of particular neu-
rons (Slaker et al., 2016). In the cortex and hippocampus, the PNN is
mainly formed around parvalbumin-positive GABAergic interneurons
(Slaker et al., 2016). The PNN maintains the cellular ion homeostasis of
highly active neurons (Brückner et al., 1993; Härtig et al., 1999), sta-
bilizes synaptic connections, and regulates synaptic plasticity (Kalb and
Hockfield, 1994; Pizzorusso et al., 2002). The PNN is formed in the late
phase of the developmental period and is considered to control the
critical period of brain development because it is related to the end of
synaptic plasticity. Depending on the constituent CSPG, the PNN hin-
ders the formation of new synaptic connections by inhibiting axonal
sprouting (McKeon et al., 1995; Smith-Thomas et al., 1995; Zuo et al.,
1998). Therefore, it has been reported that synaptic plasticity of the
mature visual cortex is restored by denaturing CSPG on PNNs with
chondroitinase ABC injection (ChABC) (Pizzorusso et al., 2002; Berardi
et al., 2004). In addition, PNNs protect the surrounding neurons from
oxidative stress and glutamate-stimulated excitotoxicity (Okamoto
et al., 1994; Morawski et al., 2004).
On the other hand, the PNN is frequently expressed in the spinal
cord (Jäger et al., 2013). However, it is considered that it is not the PNN
itself but ECM molecules that inhibit axonalits axon outgrowth (Gaudet
and Popovich, 2014). Even in the cortex and hippocampus, parval-
bumin-positive neurons surrounded by PNNs alone are not responsible
for neuroplasticity preservation and protective function, but there is a
high possibility that ECM molecules dispersed in granular form also
have similar functions.
Changes in ECM molecules have been reported in the brains of
patients with Alzheimer's disease (AD) and schizophrenia (Bonneh-
Barkay and Wiley, 2009; Pantazopoulos et al., 2010). However, the
related cause and mechanism remain unknown. Reportedly, ECM mo-
lecules are implicated in the etiology of AD (Brückner et al., 1999), and
it has been suggested that ECM structure has a neuroprotective function
in AD (Morawski et al., 2010). It has been reported that PNN protects
neurons from amyloid beta toxicity and oxidative stress (Miyata et al.,
2007; Suttkus et al., 2014). Neurons surrounded by PNNs are less prone
to neurofibrillary tangles in AD. In patients with AD or schizophrenia,
disorders only occur in specific brain regions and they may be due to
brain region-specific ECM molecule expression. Changes in ECM mo-
lecules in several diseases have been investigated, but the differences
among ECM components and expression levels in normal brain regions
and each layer remain unclear.
Quantitative analysis of ECM molecules in each brain region and
each layer has not been performed, which is important to elucidate the
role of ECM molecules in normal and pathological conditions. In this
study, we mainly examined the diffuse ECM molecules. We examined
the layer-specific expression of several CSPGs (aggrecan, neurocan, and
brevican), tenascin-R, WFA-positive molecules, hyaluronic acid, and
link protein (cartilage link protein 1 (Crtl1/Hapln1)) in the somato-
sensory and piriform cortices of mature mice. Furthermore, changes in
WFA-positive molecules in these cortices due to aging were analyzed.
WFA binds to N-acetylgalactosamine, terminal ends of CSPGs
(Nakagawa et al., 1986; Härtig et al., 1992; Brückner et al., 1993;
Schweizer et al., 1993; Seeger et al., 1994). AB1031 used to label ag-
grecan recognizes the central protein domain in the chondroitin sulfate
glycosaminoglycan binding region of aggrecan (Giamanco et al., 2010;
Lendvai et al., 2013). Cat-315 is an antibody recognizing HNK-1 car-
bohydrate epitope of aggrecan (Matthews et al., 2002; Dino et al., 2006;
McRae et al., 2007). Revealing the distribution of ECMmolecules would
contribute to the elucidation of these functions in neurodegenerative
and neuropsychological diseases.
Experimental procedures
Animals
Male mice (C57BL/6 N) were used for experiments. We used male
mice for these studies in order to eliminate the effects of the estrous
cycle in females. The mice were divided into six groups according to
age: postnatal week 2 (2w; n=5), 3 w (n=5), 4 w (n=5), 11 w
(n= 5), 1 years old (1y; n=5), and 2y (n= 5). Mice were housed five
to a cage under standard laboratory conditions. All procedures related
to animal maintenance and experimentation were approved by the
Committee for Animal Experiments at Kawasaki Medical School
Advanced Research Center and conformed to the U.S. National
Institutes of Health (NIH) Guide for the Care and Use of Laboratory
Animals (NIH Publication No. 80-23, revised in 1996). We purchased
the mice from Charles River Laboratories (Kanagawa, Japan). The mice
were housed in cages including the provision of nesting material with
food and water provided ad libitum, under light/dark conditions (lights
on at 7:00 A.M., lights off at 9:00 P.M.) and temperature maintained at
23–26 °C.
Tissue preparation
Mice were anesthetized with a lethal dose of sodium pentobarbital
(120mg/kg, i.p.) and transcardially perfused with 25mL of phosphate-
buffered saline (PBS) followed by 100mL of 4% paraformaldehyde in
PBS (pH 7.4). Brains were dissected and post-fixed overnight at 4 °C in
the above fixative. The brains were then cryoprotected in 15% sucrose
for 12 h followed by 30% sucrose for 20 h at 4 °C. Next, the brains were
frozen in an optimum cutting temperature compound (Tissue-Tek;
Sakura Finetek, Tokyo, Japan) using a slurry of normal hexane in dry
ice. Serial coronal sections with a thickness of 40-μm were obtained at
−20 °C using a cryostat (CM3050S; Leica Wetzlar, Germany). The
sections were collected in ice-cold PBS containing 0.05% sodium azide.
Immunohistochemistry
We treated the cryostat sections with 0.1% Triton X-100 with PBS at
room temperature for 15min. After three washes with PBS, we in-
cubated the sections with 10% normal goat serum (ImmunoBioScience
Corp., Mukilteo, WA) in PBS at room temperature for 1 h, we washed
them three times with PBS, and incubated them overnight at 4 °C in PBS
containing biotinylated WFA (B-1355, Vector Laboratories; 1:200) and
the antibodies described in the subsection Antibodies and Lectins. After
washing with PBS, we incubated the sections with the corresponding
secondary antibodies (described in the subsection Antibodies and lec-
tins) and Alexa Fluor 594-conjugated streptavidin (S11227; Molecular
Probes, Eugene, OR) at room temperature for 2 h. We rinsed the labeled
sections again with PBS and we mounted them on glass slides with
Vectashield medium (H-1400; Vector Laboratories, Funakoshi Co.,
Tokyo, Japan). We stored the prepared slides at 4 °C until we used them
in the microscopy analysis.
Antibodies and lectins
We used the following lectins and primary antibodies for staining:
biotinylated WFA (B-1355, Vector Laboratories; 1:200), biotinylated
HABP (385911; MERCK; 1:200), goat anti-Crtl1/Hapln1 (AF260, R&D
Systems, Minneapolis, MN, USA; 1:50), goat anti-tenascin-R (AF3865, R
&D Systems; 1:200), rabbit anti-aggrecan (AB1031, MERCK; 1:200),
sheep anti-neurocan (AF5800, R&D Systems, 1:25), sheep anti-brevican
(AF4009, R&D Systems, 1:200), mouse anti-aggrecan (Cat-315;
MAB1581, MERCK; 1:1000), mouse anti-GAD67 (clone 1G10.2,
MAB5406; Millipore, Bedford, MA; 1:1,000), and guinea pig anti-
VGLUT1 (AB5905; Millipore; 1:1,000) (Table 1).
We used the following secondary antibodies for visualization: Alexa
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Fluor 488-conjugated goat anti-mouse IgG (ab150113; Abcam,
Cambridge, MA; 1:1,000), Alexa Fluor 594-conjugated goat anti-guinea
pig (A-11076; Thermo Fisher Scientific, Waltham, MA; 1:500), FITC-
conjugated anti-mouse IgM (sc-2082, Santa Cruz Biotechnology, Santa
Cruz, CA, 1:1000), Alexa Fluor 488-conjugated goat anti-rabbit IgG
(ab150077, Abcam; 1:1000), DyLight 488-conjugated horse anti-goat
IgG (DI-3088; Vector Laboratories; 1:500), Alexa Fluor 488-conjugated
donkey anti-sheep IgG (A-11015; Thermo Fisher Scientific, 1:500), and
streptavidin-conjugated Alexa Fluor 594 (S11227, Thermo Fisher
Scientific; 1:1000).
Microscopy imaging
For quantification of the density of WFA-positive PNNs and analysis
of ECM fluorescence intensities, we used confocal laser scanning mi-
croscopy (LSM700; Carl Zeiss, Oberkochen, Germany) to obtain images
of stained sections. Images (1024× 1024 pixels) were saved as TIFF
files using the ZEN software (Carl Zeiss). Briefly, we performed the
analysis using a 10× objective lens and a pinhole setting that corre-
sponded to a focal plane thickness of less than 1 μm. For observing ECM
molecules, GAD67- and VGLUT1-positive synaptic terminals, samples
were randomly selected and high-magnification images using a 100×
objective lens were acquired. Prior to capture, the exposure time, gain,
and offset were carefully set to ensure a strong signal but to avoid sa-
turation. Identical capture conditions were used for all sections. Images
from whole sections were acquired using a 10× objective lens of a
fluorescence microscope (BZ-X; KEYENCE, Tokyo, Japan) and we
merged them using the KEYENCE BZ-X Analyzer software (KEYENCE).
Quantification of labeled PNNs and ECMs
Brain areas were determined according to the atlas by Paxinos and
Franklin (2012). Data shown in the figures are presented according to
the cortical layer profiles based on fluorescence Nissl staining (Neuro-
Trace 435/455 blue: N-21479, Molecular Probes). We stored all con-
focal images as TIFF files and analyzed them using the NIH ImageJ
software (Bethesda, MD; http://rsb.info.nih.gov/nih-image/). From
each mouse, four coronal sections containing somatosensory cortex and
piriform cortex (from -0.8 mm to -1.8 mm relative to bregma) were
selected and processed for staining. We manually tagged stained PNNs
(soma size larger than 60 μm2) in the region of interest and counted
them. PNN density was calculated as cells/mm2. Quantifications were
performed by a blinded independent observer. For quantifying the
fluorescence intensity of ECM-positive molecules and WFA-positive
PNNs, we selected four sections from each mouse brain and stained
them as described above. The ellipse circumscribing the WFA-positive
PNNs was traced manually on 8-bit images of each section, and the gray
levels for WFA labeling were measured using the ImageJ software,
which was assigned arbitrary units (a.u.). We manually outlined the
parts excluding PNNs and measured the gray level with NIH ImageJ.
Background intensity was subtracted using unstained portions of each
section. We acquired all confocal images as TIFF files and analyzed
them with NIH ImageJ. We coded the slides and a blinded independent
observer quantified them.
Data analysis
Data are expressed as box plots of five animals per group. Statistical
significance was determined by two-way analysis of variance followed
by the Bonferroni t-tests. The statistical significance threshold was set at
p < 0.05.
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Results
Extracellular matrix molecules in the mouse somatosensory cortex
To examine the spatial distribution of ECM molecules, we stained
for WFA, HABP, Hapln1, tenascin-R, AB1031, neurocan, brevican, and
Cat-315. ECM molecules were expressed in the neuropil of the mouse
somatosensory and piriform cortices at 11 w (Figs. 1 and 2). Their
distribution pattern was region-specific and layer-specific (Figs. 1A–H,
and 2 A–H). In the somatosensory cortex, the highest level of ECM
molecule expression was observed in layer 4 (L4) (Fig. 1A–H). In the
piriform cortex, the highest level of ECM molecule expression was
observed in the upper level of L1 (L1A) (Fig. 2A–H). High magnification
showed that ECM molecules in granular form were scattered
throughout the cortical layers of the mouse somatosensory and piriform
cortices (Figs. 1a–h, a’–h’, a’’–h’’, 2 a–h). In addition, ECM molecules
revealed a characteristic pattern of PNN formation in the mouse so-
matosensory cortex (Fig. 1a–h, a’–h’, a’’–h’’).
Comparative distribution of ECM molecules in the mouse somatosensory and
piriform cortices
To examine whether ECM molecules may differ per cortical layer,
we quantified layer-specific WFA, HABP, Hapln1, tenascin-R, AB1031,
Fig. 1. Extracellular matrix molecules in the
mouse somatosensory cortex.
Representative images show the laminar dis-
tribution of WFA-positive molecules (A),
HABP-positive molecules (B), Hapln1-positive
molecules (C), tenascin-R-positive molecules
(D), AB1031-positive molecules (E), neurocan-
positive molecules (F), brevican-positive mo-
lecules (G), Cat-315-positive molecules (H),
and Nissl-positive cells (I) in the somatosen-
sory cortex. High-magnification confocal
images of WFA (a, a’, a’’), HABP (b, b’, b’’),
Hapln1 (c, c’, c’’), tenascin-R (d, d’, d’’),
AB1031 (e, e’, e’’), neurocan (f, f’, f’’), brevican
(g, g’, g’’), and Cat-315 (h, h’, h’’) labeling in
L2/3 (a–h), L4 (a’–h’), and L5B (a’’–h’’) of the
mouse somatosensory cortex at postnatal week
11. Scale bars: 100 μm in I (applies to A–I); 5
μm in h’’ (applies to a–h, a’–h’, a’’–h’’).
Fig. 2. Extracellular matrix molecules in the
mouse piriform cortex.
Representative images show the laminar dis-
tribution of WFA-positive molecules (A),
HABP-positive molecules (B), Hapln1-positive
molecules (C), tenascin-R-positive molecules
(D), AB1031-positive molecules (E), neurocan-
positive molecules (F), brevican-positive mo-
lecules (G), Cat-315-positive molecules (H) and
Nissl-positive cells (I) in the mouse piriform
cortex at postnatal week 11. High-magnifica-
tion confocal images of WFA (a), HABP (b),
Hapln1 (c), tenascin-R (d), AB1031 (e), neu-
rocan (f), brevican (g), and Cat-315 (h) la-
beling in L1A (a–h) of the mouse piriform
cortex at postnatal week 11. Scale bars: 100
μm in I (applies to A–I); 5 μm in h (applies to
a–h).
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neurocan, brevican, and Cat-315-positive signal intensity, excluding the
PNN area, in the mouse somatosensory cortex at 11 w (Fig. 3A–H,
Table 2A), and mouse piriform cortex at 11 w (Fig. 4A–H, Table 2B).
The fluorescence intensities of these ECM molecules were layer-specific.
In the mouse somatosensory cortex, the fluorescence intensity of
ECM molecules showed significant variation among the layers. WFA-
positive fluorescence intensity in L4 was very high compared with that
in the other layers (Fig. 3A, Table 2A). WFA-positive fluorescence in-
tensity in L1 was very low compared with that in the other layers. There
was minor difference in the expression of HABP-positive molecules
among the layers (Fig. 3B, Table 2A). Hapln1-positive fluorescence
intensity in L4 was very high compared with that in the other layers
(Fig. 3C, Table 2A). There was minor difference in the expression of
tenascin-R-positive fluorescence intensity between the layers (Fig. 3D,
Table 2A). AB1031-positive fluorescence intensity in L4 was very high
compared with that in the other layers (Fig. 3E, Table 2A). Neurocan-
positive fluorescence intensity in L1 was very high compared with that
in the other layers (Fig. 3F, Table 2A). Brevican-positive fluorescence
intensity in L4 was high compared with that in L1, L5 A, L5B, and L6
(Fig. 3G, Table 2A). Cat-315-positive fluorescence intensity in L4 was
very high compared with that in the other layers (Fig. 3H, Table 2A).
In the mouse piriform cortex, the fluorescence intensity of ECM
molecules also showed significant variation among the layers at 11 w.
WFA-positive fluorescence intensity in L1A was significantly high
compared with that in the other layers (Fig. 4A, Table 2B). HABP-po-
sitive fluorescence intensity in L3 was very high compared with that in
the other layers (Fig. 4B, Table 2B). Hapln1-positive fluorescence in-
tensity in L1A was very high compared with that in the other layers
(Fig. 4C, Table 2B). Tenascin-R-positive fluorescence intensity in L1A
and L3 was high compared with that in L1B and L2 (Fig. 4D, Table 2B).
Both AB1031- and Neurocan-positive fluorescence intensities in L1A
were very high compared with that in the other layers (Fig. 4E, F
Table 2B). Neurocan-positive fluorescence intensity in L2 was low
compared with that in the other layers. Brevican-positive fluorescence
intensity in L1A was very high compared with that in the other layers
(Fig. 4G, Table 2B). Cat-315-positive fluorescence intensity in L1A was
very high compared with that in the other layers (Fig. 4H, Table 2B).
ECM molecules in L1A of the mouse piriform cortex
As many ECM molecules were expressed in L1A of the mouse piri-
form cortex at high concentration, we observed ECM molecules at high
magnification. High magnification images revealed WFA, HABP,
Hapln1, tenascin-R, AB1031, neurocan, brevican, and Cat-315-positive
molecules scattered throughout L1A (Fig. 5A–G, A’-G’). WFA-positive
molecules did not colocalize with HABP, Hapln1, tenascin-R, AB1031,
neurocan, brevican, and Cat-315-positive molecules in L1A of the
mouse piriform cortex at 11 w (Fig. 5A’’–G’’).
GABAergic and glutamatergic synaptic terminals in the mouse
somatosensory and piriform cortices
To investigate the distribution relationship between the synaptic
terminal and ECM molecules, we labeled both GAD67-positive synaptic
terminals and VGLUT1-positive synaptic terminals (Fig. 6A–D). GAD67-
and VGLUT1-positive synaptic terminals were expressed in the neuropil
Fig. 3. Quantitative analyses of extracellular matrix molecules in the mouse somatosensory cortex.
Quantified mean fluorescence intensity of WFA-positive molecules (A), HABP-positive molecules (B), Hapln1-positive molecules (C), tenascin-R-positive molecules
(D), AB1031-positive molecules (E), neurocan-positive molecules (F), brevican-positive molecules (G), and Cat-315-positive molecules (H), excluding the PNN, in the
mouse somatosensory cortex at postnatal week 11. Data are expressed as box plots. *p < 0.05 for comparison between layers. The respective p values are listed in
Table 2.
WFA: F(5,269) = 196.641 in.(A). p < 0.001, HABP: F(5,143) = 6.772, p < 0.001 in.(B), Hapln1: F(5,269) = 35.132, p < 0.001 in.(C), tenascin-R: F(5,269)= 2.986,
p= 0.012 in.(D), AB1031: F(5,228) = 32.250, p < 0.001 in.(E), neurocan: F(5,269) = 36.797, p < 0.001 in.(F). brevican: F(5,228) = 16.721, p < 0.001 in.(G), Cat-
315: F(5,251) = 23.139, p < 0.001 in.(H).
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of the mouse somatosensory and piriform cortices at 11 w (Fig. 6A–D).
Their distribution pattern was also region-specific and layer-specific
(Fig. 6A–D). We quantified layer-specific GAD67- and VGLUT1-positive
signal intensities, excluding GAD67-positive neurons, in the somato-
sensory cortex (Fig. 6E, F, Table 2C) and piriform cortex (Fig. 6G, H,
Table 2D). In the somatosensory cortex, GAD67-positive fluorescence
intensity in L4 was very high compared with that in the other layers
(Fig. 6E, Table 2C). GAD67-positive fluorescence intensity in L1 was
low compared with that in the other layers. VGLUT1-positive fluores-
cence intensity in L1 was very high compared with that in the other
layers (Fig. 6F, Table 2C). In the piriform cortex, GAD67-positive
fluorescence intensity in L1A was very high compared with that in the
other layers (Fig. 6G, Table 2D). VGLUT1-positive fluorescence in-
tensity in L2 was very low compared with that in the other layers
(Fig. 6H, Table 2D).
High magnification showed that GAD67- and VGLUT1-positive sy-
naptic terminals were scattered throughout the cortical layers in
granular form in the mouse somatosensory cortex (Fig. 7A–L). These
GAD67- and VGLUT1-positive synaptic terminals did not colocalize
with WFA-positive molecules in all layers of the mouse somatosensory
cortex (Fig. 7A’’–L’’). In addition, GAD67- and VGLUT1-positive sy-
naptic terminals were also present in PNNs (Fig. 7M–N, M’–N’, M’’–N’’).
As GAD67- and VGLUT1-positive molecules were expressed in L1A
of the mouse piriform cortex at high concentration, we observed these
synaptic terminals at high magnification (Fig. 5H, I). GAD67- and
VGLUT1-positive synaptic terminals did not colocalize with WFA-po-
sitive molecules in L1A of the mouse piriform cortex (Fig. 5H’’, I’’).
Effect of aging on WFA-positive molecules in the mouse somatosensory and
piriform cortices
Next, we examined the developmental expression of WFA-positive
molecules in the somatosensory and piriform cortices with age. WFA-
positive molecules were already present in both cortices at 2 w
(Fig. 8A–C). We observed that WFA-positive intensity at 2 w was weak
within the somatosensory and piriform cortices compared to the in-
tensity in both cortices at 11 w (Fig. 8A–C). Intense WFA-positive signal
intensity was seen in L1A of the piriform cortex at 4 w (Fig. 8C). WFA-
positive signal intensity in both cortices significantly decreased from
11w to 2y (Fig. 8A–C).
We observed the formation of reticular-like WFA-positive PNNs in
these cortices with age (Fig. 8D, E). At 2 w, in the somatosensory cortex,
WFA-positive PNNs showed attenuated staining. WFA-positive PNNs
were sparse and less condensed in L2/3 of the somatosensory cortex at
2 w (Fig. 8D). At 11w, WFA-positive PNNs exhibited a clear condensed
reticular-like structure (Fig. 8D). At 2 w, WFA-positive PNNs were not
Fig. 4. Quantitative analyses of extracellular matrix molecules in the mouse piriform cortex.
Quantified mean fluorescence intensity of WFA-positive molecules (A), HABP-positive molecules (B), Hapln1-positive molecules (C), tenascin-R-positive molecules
(D), AB1031-positive molecules (E), neurocan-positive molecules (F), brevican-positive molecules (G), and Cat-315-positive molecules (H), excluding the PNN, in the
mouse piriform cortex at postnatal week 11. Data are expressed as box plots. *p < 0.05 for comparison between layers. The respective p values are listed in Table 2.
WFA: F(3,179) = 354.682, p < 0.001 in.(A). HABP: F(3,95) = 68.170, p < 0.001 in.(B). Hapln1: F(3,191) = 126.329, p < 0.001 in.(C). tenascin-R: F(3,143) = 42.447,
p < 0.001 in.(D). AB1031: F(3,155) = 221.711, p < 0.001 in.(E). neurocan: F(3,143) = 54.192, p < 0.001 in.(F). brevican: F(3,167) = 28.465, p < 0.001 in.(G). Cat-
315: F(3,143) = 30.712, p < 0.001 in.(H).
H. Ueno et al. IBRO Reports 6 (2019) 1–17
7
observed in the piriform cortex (Fig. 8C), but were present at 4 w
(Fig. 8C, E). We observed WFA-positive molecules in L1A of the piri-
form cortex at 2 w (Fig.8C, E). Intense WFA-positive signal intensity
was seen in L1A of the piriform cortex at 4 w (Fig. 8E). At 11 w, WFA-
positive PNNs in L3 of the piriform cortex showed condensed staining
compared to that at 4 w. WFA-positive signal intensity in L3 of the
piriform cortex significantly decreased from 11w to 2y.
Quantitative analysis of WFA-positive PNNs and WFA-positive molecules in
the mouse somatosensory cortex with age
First, we quantified WFA-positive PNNs in the mouse somatosensory
cortex (Fig. 9A, Table 3A). The mean WFA-positive PNN density in-
creased between 2w and 2y. The density of WFA-positive PNNs sig-
nificantly increased in L4 of the somatosensory cortex.
To analyze the effect of aging on the expression of WFA-positive
molecules, we analyzed the fluorescence intensity of each WFA-positive
PNN in the mouse somatosensory cortex with age (Fig. 9B, Table 3B).
The mean fluorescence intensity of WFA-positive PNNs increased be-
tween 2w and 2y. The fluorescence intensity of WFA-positive PNNs
differed in each of the cortical layers and at each age.
Next, we analyzed WFA-positive molecules, excluding PNNs, in the
mouse somatosensory cortex with age (Fig. 9C, Table 3C). The mean
fluorescence intensity of WFA-positive molecules, excluding PNNs, in-
creased between 2w and 3w. In L1, 2/3, and 5 A, we observed a sig-
nificant decrease in the fluorescence intensity of WFA-positive mole-
cules, excluding PNNs, between 11 w and 2y. In L4, 5B, and L6, there
was an increase in the fluorescence intensity of WFA-positive mole-
cules, excluding PNNs, between 1y and 2y.
Quantitative analysis of WFA-positive PNNs and WFA-positive molecules in
the mouse piriform cortex with age
We quantified WFA-positive PNNs in the mouse piriform cortex
(Fig. 10A, Table 3D). The mean WFA-positive PNNs density increased
between 3w and 11w. The density of WFA-positive PNNs significantly
decreased in the piriform cortex.
Next, we analyzed the fluorescence intensity of each WFA-positive
PNN in the mouse piriform cortex with age (Fig. 10B, Table 3E). The
mean fluorescence intensity of WFA-positive PNNs increased between
3w and 11w. There was a decrease in the fluorescence intensity of
WFA-positive PNNs between 11w and 2y.
We analyzed WFA-positive molecules excluding PNNs in the mouse
piriform cortex with age (Fig. 10C, Table 3F). In L1A, the mean fluor-
escence intensity of WFA-positive molecules, excluding PNNs, increased
between 2w and 4w. In L1B, L2, and L3, the mean fluorescence in-
tensity of WFA-positive molecules, excluding PNNs, increased between
2w and 11w. In all layers, we observed a significant decrease in the
fluorescence intensity of WFA-positive molecules, excluding PNNs,
between 11w and 2y.
Discussion
In this study, we analyzed the expression levels of WFA-positive
molecules, aggrecan, brevican, neurocan, tenascin-R, Hapln1, and
hyaluronic acid, in each layer of the somatosensory and piriform cor-
tices of mature mice using histochemical and immunohistological
techniques. In the mature mouse cortex, these ECM molecules showed
brain region-specific, layer-specific, and ECM molecule-specific ex-
pression. High magnification observation by confocal laser microscopy
revealed that ECM molecules are present in the extracellular region at
high density in the mature cortex, in addition to the PNN area. In ad-
dition, the WFA-positive molecules existing outside the PNN area
showed region-dependent variation with age.
The expression level of ECM molecules was lower in the other re-
gions than in the PNN area, but there were no layers without ECM
Fig. 5. Colocalization of extracellular matrix molecules and WFA in the mouse
piriform cortex.
Double confocal images of HABP (A), Hapln1 (B), tenascin-R (C), AB1031 (D),
neurocan (E), brevican (F), Cat-315 (G), GAD67 (H), VGLUT1 (I), WFA (A’–I’),
and merged images (A’’–I’’) in the upper level of L1 of the mouse piriform cortex
at postnatal week 11. Scale bars: 5 μm in I’’ (applies to A–I, A’–I’, A’’–I’’).
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molecules. In the extracellular region outside the PNN area, it is pre-
sumed that migration is difficult for neurons and glial cells with a
diameter of approximately 10 μm. Even axons with a diameter of 1–2
μm are unlikely to easily outgrow. It has been widely reported that
neuronal plasticity is restored by ChABC injection in the CNS
(Pizzorusso et al., 2006; Gogolla et al., 2009; de Vivo et al., 2013;
Senkov et al., 2014). These reports have indicated that PNN destruction
by ChABC is the mechanism underlying neural plastic resurgence.
ChABC removes the CS chain from the lectican core protein. However,
the present study revealed that there are numerous WFA-positive mo-
lecules (CS chains) other than in the PNN area. That is, at the time of
ChABC treatment, it is suggested that not only PNNs, but also other
WFA-positive molecules are subjected to enzyme treatment. It is ob-
vious that axon elongation is also facilitated if ECM molecules in the
extracellular region are removed by ChABC. Moreover, in mice lacking
specific PNN components, such as Crtl1, PNN formation decreases and
neural plasticity increases (Carulli et al., 2010). PNN formation is re-
duced in cultured neurons of neurocan-, brevican-, or TN-R-deficient
mice. In these neurons, changed synaptic plasticity, decreased sy-
naptogenesis, decreased synaptic stability, and decreased synaptic ac-
tivity are observed (Geissler et al., 2013). In these reports, changes,
such as in synaptic plasticity, attributable to lack of ECM molecules are
only suggested due to impaired PNN formation. However, considering
the results of this study, ECM molecules, other than the PNN area, also
lack expression in these deficient mice. Therefore, it is possible that
ECM malfunction involved in other areas may be implicated in the in-
crease in neural plasticity. This study suggests that further research to
reconsider the mechanism of reactive neuronal plasticity is necessary.
Each component of the ECM molecule showed layer-dependent
distribution. These characteristic layer-specific expressions indicate
that ECM molecules play diverse roles in these layers. ECM structure in
the brain has also been shown to function as a physical barrier to
prevent lateral diffusion of AMPA receptors in postsynaptic sites
(Frischknecht et al., 2009; Frischknecht and Gundelfinger, 2012). In
addition, ECM molecules have been reported to regulate several ion
channels; for example, tenascin-R regulates sodium channels
(Srinivasan et al., 1998). Furthermore, hyaluronic acid regulates L-type
calcium and potassium channels (Davis et al., 2002; Evers et al., 2002;
Kochlamazashvili et al., 2010). Brevican has been shown to be sig-
nificantly involved in nerve excitability in the axon initial segment
(John et al., 2006). CSPG regulates the diffusion of Ca2+ in brain tissue
(Hrabetová et al., 2009). We also showed that both the GAD67-positive
inhibitory synaptic terminal and the VGLUT1-positive excitatory sy-
naptic terminal were differentially expressed in each brain area and
each layer. This result shows that the neuronal transmitters and re-
ceptors are region-specific and layer-specific. That is, if neuro-
transmitters and excitability differ in each brain region and layer, ECM
molecules playing roles in that region and layer would also differ. The
results of this study are consistent with those of previous reports. Fur-
ther studies are needed to analyze the function of each ECM molecule in
the synaptic cleft.
On the other hand, we did not control for the differences in cell
density, soma shape/size and layer volumes. The difference in cell
density, cell shape/size, and layer volume may have influenced the
present results. We used same analytical method as other studies de-
monstrating the distribution of molecules in the extracellular region of
the CNS (Barker et al., 2012; Risher et al., 2014; Moyer et al., 2016;
Sceniak et al., 2016; Bolós et al., 2018). In order to clarify the difference
Fig. 6. GAD67-positive and VGLUT1-positive
puncta in the mouse somatosensory and piri-
form cortices.
Representative images show the laminar dis-
tribution of GAD67-positive puncta (A) and
VGLUT1-positive puncta (B) in the mouse so-
matosensory cortex at postnatal week 11.
Representative images show the laminar dis-
tribution of GAD67-positive puncta (C) and
VGLUT1-positive puncta (D) in the mouse
piriform cortex at postnatal week 11. Scale
bars: 100 μm in D (applies to A–D). Quantified
mean fluorescence intensity of GAD67-positive
puncta (E) and VGLUT1-positive puncta (F),
excluding the GAD67-positive neurons, in the
mouse somatosensory cortex at postnatal week
11. Quantified mean fluorescence intensity of
GAD67-positive puncta (G) and VGLUT1-posi-
tive puncta (H), excluding the GAD67-positive
neurons, in the mouse piriform cortex at week
11. Data are expressed as box plots. *p < 0.05
for comparison between layers. The respective
p values are listed in Table 2.
GAD67: F(5,239) = 148.527, p < 0.001 in.(E).
VGLUT1: F(5,143) = 28.293, p < 0.001 in.(F).
GAD67: F(3,127) = 63.110, p < 0.001 in.(G).
VGLUT1: F(3,111) = 60.856, p < 0.001 in.(H).
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in layer-specific expressions of ECM molecules in each layer, it is ne-
cessary to consider cell density, soma shape/size and layer volumes.
L4 in the somatosensory cortex receives direct inputs from the
thalamus and then conveys that information to L2/3 (Winer et al.,
2005; Schiff and Reyes, 2012). In L4 of the somatosensory cortex, the
GAD67-positive synaptic terminal is expressed at high density and the
excitation by the input from the hypothalamus is inhibited (Jiao et al.,
2006). In this study, it is speculated that WFA-positive molecules, ag-
grecan, Hapln1, and brevican, are highly expressed in L4 compared to
the other layers and that they play a role in synaptic transmission.
Additionally, L4 is a region with many PV-positive neurons surrounded
by PNNs (McRae et al., 2007). High ECM expression in L4 may be due
to high PNN density. However, why PNNs with ECM molecules accu-
mulate around PV-positive neurons remains unknown, but it is re-
portedly related to the electrical characteristics of fast-spiking neurons
(Morris and Henderson, 2000).
The piriform cortex is associated with the sensory cortex, which is
indispensable for recognition and odor memory (Isaacson, 2010;
Bekkers and Suzuki, 2013). Interestingly, the piriform cortex shows
long-term plasticity (Strauch and Manahan-Vaughan, 2018). However,
it is also a brain region where abnormalities are seen in patients with
epilepsy and AD (Li et al., 2010; Vaughan and Jackson, 2014). We
found high expression of ECM molecules in L1 of the piriform cortex
compared with that in the other layers. L1 of the cortex is a special layer
with no pyramidal cells present. L1 has axons from 2 to 6 layers of
pyramidal cells and of inhibitory interneurons from other cortical re-
gions (Felleman et al., 1991; Vogt et al., 1991). Glutamatergic, GA-
BAergic, cholinergic, noradrenergic, and serotoninergic axons coexist in
L1 on the apical dendrites of pyramidal cells of 2–6 layers (Vogt et al.,
1991). Consistent with these reports, our results showed that both
GAD67- and VGLUT1-positive synaptic terminals were more highly
expressed in this than in the other layers. It is suggested that the ECM
Fig. 7. Distribution of GAD67-positive and
VGLUT1-positive puncta in the mouse soma-
tosensory cortex.
Double confocal images of GAD67 (A–F), WFA
(A’–F’), and merged images (A’’–F’’) in L1 (A,
A’, A’’), L2/3 (B, B’, B’’), L4 (C, C’, C’’), L5 A (D,
D’, D’’), L5B (E, E’, E’’), and L6 (F, F’, F’’) of the
mouse somatosensory cortex at postnatal week
11. Double confocal images of VGLUT1 (G–L),
WFA (G’–L’), and merged images (G’’–L’’) in L1
(G, G’, G’’), L2/3 (H, H’, H’’), L4 (I, I’, I’’), L5 A
(J, J’, J’’), L5B (K, K’, K’’), and L6 (L, L’, L’’) of
the mouse somatosensory cortex at postnatal
week 11. The same capture conditions were
used for all section images. High-magnification
double confocal images of GAD67 (M), WFA
(M’), and merged image (M’’) around PNNs in
L2/3 of the mouse somatosensory cortex at
postnatal week 11. High-magnification double
confocal images of VGLUT1 (N), WFA (N’), and
merged image (N’’) around PNNs in L2/3 of the
mouse somatosensory cortex at postnatal week
11. Scale bars: 5 μm in L’’ (applies to A–L,
A’–L’, A’’–L’’); 5 μm in M’’ (applies to M, M’,
M’’); 5 μm in N’’ (applies to N, N’, N’’).
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molecules showed high expression level due to the high density of sy-
naptic terminals in L1A. ECM molecules formed in the synaptic cleft
restrict spine dynamics and functional plasticity (Levy et al., 2014).
Therefore, if abnormality occurs in ECM molecules in L1A of the piri-
form cortex, spine and synaptic transmission abnormalities will also
occur. Studies to analyze the association between L1 synapse of the
piriform cortex and the ECM molecule are necessary.
In the somatosensory cortex, the number of WFA-positive PNNs,
WFA-positive PNN fluorescence intensity, and WFA-positive ECM mo-
lecule fluorescence intensity increased with age. It is generally known
that neuronal plasticity decreases with aging (Burke and Barnes, 2006).
Compared with young adult mice, in aged mice, the number of WFA-
positive PNNs increases in the somatosensory cortex (Karetko-Sysa
et al., 2014; Ueno et al., 2018). WFA-positive PNNs are formed at the
final stage of maturation of the inhibitory neuronal circuit, and WFA-
positive PNN expression is confirmed approximately 2 weeks after birth
Fig. 8. The effect of aging on WFA-positive
molecules in the mouse somatosensory and
piriform cortices.
Representative whole-brain sections labeled for
WFA in 2-week-old (A, left panels), 11-week-
old (A, central panels), and 2-year-old mice (A,
right panels). Representative images show the
laminar distribution of WFA-positive molecules
in the mouse somatosensory cortex (B) and
piriform cortex (C). The same capture condi-
tions were used for all section images.
Representative morphologies of WFA-positive
PNNs in L2/3 (D, upper layers) and L4 (D,
down layers) of the somatosensory cortex.
Representative distribution of WFA-positive
molecules in L1A (E, upper layers) and WFA-
positive PNN L3 (E, down layers) of the piri-
form cortex. Scale bars: 100 μm in C (applies to
B–C); 5 μm in E (applies to D–E).
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in the mouse somatosensory cortex (Ueno et al., 2017). Increase in the
number of WFA-positive PNNs, WFA-positive PNN fluorescence in-
tensity, and WFA-positive ECM molecule fluorescence intensity in-
dicates decrease in plasticity of the somatosensory cortex.
Conversely, in the piriform cortex, unlike the somatosensory cortex,
WFA-positive PNN number, WFA-positive PNN fluorescence intensity,
and WFA-positive ECM molecule fluorescence intensity increased 11
weeks after birth but decreased thereafter. These changes were not
reflected in the somatosensory cortex. Considering that the ECM mo-
lecule has plastic and neuroprotective functions, it is speculated that
plasticity and vulnerability increase in the piriform cortex of aged mice.
Studies have reported that the piriform cortex shows long-term plasti-
city (Strauch and Manahan-Vaughan, 2018) and that the piriform
cortex becomes a pathogenic region of AD due to aging (Li et al., 2010;
Fig. 9. Quantitative analyses of layer-specific aging
patterns of WFA-positive molecules and WFA-positive
PNNs in the mouse somatosensory cortex.
Quantified density of WFA-positive PNNs (A), mean
fluorescence intensity of WFA-positive PNNs (B), and
mean fluorescence intensity of WFA-positive mole-
cules, excluding the PNN, (C) in L1, L2/3, L4, L5 A,
L5B, and L6 of the mouse somatosensory cortex. Data
are expressed as box plots. Statistical significance is
represented by asterisks: *p < 0.05. Statistically sig-
nificant differences were compared with earlier age
groups. The respective p values are listed in Table 3.
L2/3: F(5,113) = 22.506, p < 0.001, L4: F(5,113) =
28.311, p < 0.001, L5 A: F(5,113) = 11.581,
p < 0.001, L5B: F(5,113) = 7.609, p < 0.001, L6:
F(5,113) = 6.063, p < 0.001 in.(A). L2/3: F(5,411) =
12.232, p < 0.001, L4: F(5,692) = 101,085,
p < 0.001, L5 A: F(5,457) = 31.012, p < 0.001, L5B:
F(5,527) = 26.022, p < 0.001, L6: F(5,455) = 16.322,
p < 0.001 in.(B). L1: F(5,344) = 21.885, p < 0.001,
L2/3: F(5,344) = 8.021, p < 0.001, L4: F(5,344) =
7.905, p < 0.001, L5 A: F(5,344) = 26.901, p < 0.001,
L5B: F(5,344) = 8.153, p < 0.001, L6: F(5,344) = 4.535,
p= 0.001 in.(C).
H. Ueno et al. IBRO Reports 6 (2019) 1–17
12
Ta
bl
e
3
p
va
lu
es
fo
r
Fi
gs
.9
an
d
10
.
A
:F
ig
.9
A
W
FA
-p
os
iti
ve
PN
N
s
/
m
m
2
L1
L2
/3
L4
L5
A
L5
B
L6
2
w
vs
3
w
0.
05
2
0.
02
1
0.
13
5
0.
02
5
0.
17
2
3
w
vs
4
w
0.
27
3
0.
49
5
0.
38
3
0.
50
4
0.
99
9
4
w
vs
0.
73
1
0.
00
4
0.
09
6
0.
31
4
0.
24
8
11
w
vs
1y
<
0.
00
1
0.
01
4
0.
25
7
0.
18
2
0.
27
4
1y
vs
2y
0.
56
9
0.
84
1
0.
51
9
0.
44
2
0.
55
B:
Fi
g.
9B
W
FA
flu
or
es
ce
nc
e
in
te
ns
ity
on
PN
N
s
(a
.u
.)
L1
L2
/3
L4
L5
A
L5
B
L6
2
w
vs
3
w
0.
05
9
<
0.
00
1
0.
00
5
<
0.
00
1
<
0.
00
1
3
w
vs
4
w
0.
06
4
<
0.
00
1
0.
10
2
0.
00
6
0.
25
8
4
w
vs
11
w
0.
01
2
<
0.
00
1
<
0.
00
1
0.
22
0.
79
3
11
w
vs
1y
0.
07
2
0.
17
4
0.
02
8
0.
73
0.
22
2
1y
vs
2y
0.
01
3
<
0.
00
1
0.
97
1
0.
16
6
0.
28
4
C:
Fi
g.
9C
W
FA
flu
or
es
ce
nc
e
in
te
ns
ity
ex
cl
ud
in
g
PN
N
s
(a
.u
.)
L1
L2
/3
L4
L5
A
L5
B
L6
2
w
vs
3
w
0.
77
0.
11
6
0.
00
1
<
0.
00
1
<
0.
00
1
<
0.
00
1
3
w
vs
4
w
<
0.
00
1
0.
24
0.
73
3
0.
57
2
0.
26
3
0.
67
6
4
w
vs
11
w
0.
53
6
0.
00
1
0.
64
5
0.
20
6
0.
11
8
0.
16
5
11
w
vs
1y
0.
02
4
<
0.
00
1
0.
00
5
<
0.
00
1
0.
09
5
0.
69
3
1y
vs
2y
<
0.
00
1
0.
05
6
<
0.
00
1
0.
50
9
0.
01
0.
04
1
D
:F
ig
.1
0A
W
FA
-p
os
iti
ve
PN
N
s
/
m
m
2
L1
A
L1
B
L2
L3
3
w
vs
4
w
0.
96
6
0.
03
2
4
w
vs
11
w
0.
03
9
<
0.
00
1
11
w
vs
1y
0.
96
9
0.
09
5
1y
vs
2y
<
0.
00
1
<
0.
00
1
E:
Fi
g.
10
B
W
FA
flu
or
es
ce
nc
e
in
te
ns
ity
on
PN
N
s
(a
.u
.)
L1
A
L1
B
L2
L3
3
w
vs
4
w
<
0.
00
1
4
w
vs
11
w
<
0.
00
1
<
0.
00
1
(c
on
tin
ue
d
on
ne
xt
pa
ge
)
H. Ueno et al. IBRO Reports 6 (2019) 1–17
13
Vaughan and Jackson, 2014). The present results will be useful for
elucidating these mechanisms, and further research is needed to de-
termine the cause of neurodegenerative disease in the piriform cortex.
It has been reported that ECM molecules inhibit axonal outgrowth
after brain trauma (McKeon et al., 1991; Silver, 1994; Asher et al.,
2001; McKeon et al., 1995). Changes in ECM molecules in the brain
have also been reported in AD (Bonneh-Barkay and Wiley, 2009),
schizophrenia (Berretta, 2012), autism (Mercier et al., 2012), and epi-
lepsy (Dityatev, 2010; Pitkänen et al., 2014). It is clear that ECM mo-
lecules are somehow related to these diseases. Studies on brain trauma
employing FeCl3 injections have shown that the size of brain injury
increases in aggrecan-, Hapln1-, and tenascin-R-deficient mice com-
pared to wild-type mice, and it has been suggested that these ECM
molecules are associated with diffusion properties (Suttkus et al.,
2014). Interestingly, it has also been reported that neuronal sensitivity
to brain injury differs depending on the brain region. Although the
mechanism of this phenomenon has not been elucidated, there is a
possibility that it involves differences in the distribution of ECM mo-
lecules. It is also known that neurons covered with PNN are less sus-
ceptible to accumulation of tau protein (Suttkus et al., 2016a,b). Re-
portedly, aggregation of tau protein leads to further aggregation of tau
protein, and extracellular tau protein species spread to neighboring
cells in neurodegenerative disease (Clavaguera et al., 2009; Frost et al.,
2009; Kfoury et al., 2012), which shows that ECM molecules are related
to aggregation of tau protein. In postmortem brain studies of patients
with schizophrenia, WFA-positive PNNs were found to decrease only in
the frontal cortex, entorhinal cortex, and amygdala (Pantazopoulos
et al., 2010; Mauney et al., 2013). The findings of these clinical studies
indicate region-specific abnormalities of CSPG. It is highly possible that
the brain region-specific ECM components and ECM expression levels
shown in the present study are involved in these neurodegenerative and
neuropsychiatric diseases and in brain trauma. Especially, the human
cortex has a higher proportion of extracellular region compared to the
mouse cortex. Therefore, it is presumed that the change in ECM in the
extracellular region has a greater impact on neurons in humans than in
mice. Further research to clarify the relationship between the ECM and
these diseases is necessary.
We demonstrated brain region-specific and layer-specific expression
of ECM molecules in the mature mouse cortex for the first time. It is
suggested that these characteristic expressions of ECM molecules reflect
specific functions of neurons, glia, and synaptic terminals present in
each region. In addition, the specific distribution of ECM molecules
with plasticity regulation and neuroprotective functions suggests that
plasticity and vulnerability differ in each brain region and each layer. In
addition, changes in ECM molecules due to aging significantly differed
in each brain region. Knowledge of the detailed expression of ECM
molecules under normal conditions would facilitate detection of cor-
tical changes associated with neuropsychiatric disorders and neurode-
generative diseases.
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